Literature DB >> 16029116

Angiogenesis in benign and malignant thyroid disease.

Jamie C Mitchell1, Sareh Parangi.   

Abstract

CONTEXT: Angiogenesis has been recognized as an important process contributing to the pathophysiology of many benign and malignant diseases. It is not surprising, therefore, that this complex process is proving to be an important regulator of both benign and malignant disease processes in the thyroid gland. This paper will review the general principles of angiogenesis and lymphangiogenesis, as well as the importance of the balance between angiogenic stimulators and inhibitors in the normal thyroid gland. We will also review how this balance is disturbed in benign and malignant thyroid conditions. Finally, we will address the role manipulation of this process may play in the development of novel treatment strategies for diseases of the thyroid.
OBJECTIVE: To review the literature concerning the role of angiogenesis in the thyroid gland.
CONCLUSIONS: Angiogenesis is an important process which has been shown to be involved in the pathophysiology of benign and malignant diseases of the thyroid gland. Manipulation of this process holds great promise for the development of novel treatments for these disorders. As the mechanisms regulating angiogenesis in the thyroid become increasingly clear, researchers will come ever closer to turning this promise into clinical reality.

Entities:  

Mesh:

Year:  2005        PMID: 16029116     DOI: 10.1089/thy.2005.15.494

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

1.  Overexpression of teneurin transmembrane protein 1 is a potential marker of disease progression in papillary thyroid carcinoma.

Authors:  Shih-Ping Cheng; Ming-Jen Chen; Ming-Nan Chien; Chi-Hsin Lin; Jie-Jen Lee; Chien-Liang Liu
Journal:  Clin Exp Med       Date:  2016-12-21       Impact factor: 3.984

2.  New targeted molecular therapies for dedifferentiated thyroid cancer.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia Martina Ferrari; Marco Sebastiani; Michele Colaci; Ilaria Ruffilli; Poupak Fallahi
Journal:  J Oncol       Date:  2010-06-06       Impact factor: 4.375

3.  Contrast-Enhanced Ultrasound: An Effective Method for Noninvasive Diagnosis of Mummified Thyroid Nodules.

Authors:  Hong Zhang; Xiaoqu Tan; Linxue Qian
Journal:  Int J Endocrinol       Date:  2022-04-27       Impact factor: 2.803

4.  Diagnostic value of contrast-enhanced ultrasound in papillary thyroid microcarcinoma.

Authors:  Hong Yan Chen; Wei Yan Liu; Hui Zhu; Dao Wen Jiang; Dong Hua Wang; Yongqi Chen; Weihua Li; Gaofeng Pan
Journal:  Exp Ther Med       Date:  2016-02-19       Impact factor: 2.447

5.  Comparison of diagnostic efficacy of contrast-enhanced ultrasound, acoustic radiation force impulse imaging, and their combined use in differentiating focal solid thyroid nodules.

Authors:  Jin Deng; Ping Zhou; Shuang-ming Tian; Lu Zhang; Jia-le Li; Ying Qian
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

6.  Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma.

Authors:  Simone Magagnin Wajner; Clarissa Capp; Beatriz Assis Brasil; Luise Meurer; Ana Luiza Maia
Journal:  Oncol Lett       Date:  2013-12-19       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.